COVID-19 situation medical genome center Ramathibodi Hospital Faculty of Medicine Post a message through the Facebook page The Center for Medical Genomics reports data from the World Health Organization (WHO) that Dr. Tedros Adhanom Ghebreyesus, WHO Director General, and Dr. Maria Y van Kerkow, WHO technical chief and head of the department for the WHO’s health emergencies programme, said, in part, emerging and zoonotic diseases:
Data from the global genetic code database of COVID-19 “Gissed” found Omicron CH.1.1 in many countries, starting with the outbreak in Austria.
• Austria, 150 cases, representing 0.209%
• England, 137 cases, which is 0.088%
• Australia, 129 cases, representing 0.246%
• US 74 cases, representing 0.011%
• Denmark, 54 cases, representing 0.060%
• Hong Kong, 27 cases, representing 0.516%
• Japan, 26 cases, representing 0.017%
• South Korea, 20 cases, representing 0.051%
• The Netherlands, 17 people, representing 0.070%
• India, 16 cases, which is 0.047%
• Liechtenstein, 13 cases, representing 3.171%
• Israel, 11 cases, representing 0.020%
• Singapore, 10 cases, representing 0.110%
• Housing 9 cases, which is 0.188%
Omicron “CH.1.1” which is a descendant of BA.2.75 because in Thailand CH.1.1 has a relative growth advantage over BA.5 about 135% and over BA.2.75 * About 150%, which makes it’ CH.1.1 is likely to spread to replace BA.5 and BA.2.75 Currently, “CH.1.1” has been found in 9 cases in Thailand.
The World Health Organization concluded that at the end of this year and next year, 2023, there is still a need for intensive PCR and new and potentially lethal pathogenic genetic sampling (genomic surveillance of COVID), while learning’ the long-term effect on people who are continuously exposed to the SARS-CoV-2 virus for more than 3 years will be more evident. including the effect of re-infection despite vaccination (innovative infection) called “mild”, including the effectiveness of the booster vaccination Especially the bivalent vaccine.
CR: Center for Medical Genomics